Harbor Capital Advisors, Inc. Verona Pharma PLC Transaction History
Harbor Capital Advisors, Inc.
- $2.38 Billion
- Q2 2025
A detailed history of Harbor Capital Advisors, Inc. transactions in Verona Pharma PLC stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 15,774 shares of VRNA stock, worth $1.42 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
15,774Holding current value
$1.42 Million% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
290Shares Held
74.3MCall Options Held
933KPut Options Held
1.98M-
Perceptive Advisors LLC New York, NY6.56MShares$591 Million17.44% of portfolio
-
Janus Henderson Group PLC London, X05.52MShares$497 Million0.2% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y93.92MShares$353 Million17.31% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.46MShares$312 Million13.82% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.89MShares$261 Million3.9% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $5.49B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...